Showing results (71-80 of 361) with videos related to
Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Cancer physicians' attitudes toward colorectal cancer follow-upC C Earle, E Grunfeld, D Coyle, et al.Oncogene|June 21, 2011
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cellsL Y W Bourguignon, C Earle, G Wong, et al.Journal of Oncology Practice|March 9, 2019
Days at Home in the Last 6 Months of Life: A Patient-Determined Quality Indicator for Cancer CareSarah K Andersen, Ruth Croxford, Craig C Earle, et al.Statistics in Medicine|October 13, 2018
Methods to improve the estimation of time-to-event outcomes when data is de-identifiedSamantha-Jo Caetano, David Dawe, Peter Ellis, et al.Current Oncology (Toronto, Ont.)|March 11, 2021
Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial ResponseRebekah Rittberg, Anmol Mann, Danielle Desautels, et al.Breast Cancer Research and Treatment|June 1, 2015
Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in OntarioSofia Torres, Maureen Trudeau, Andrea Eisen, et al.Clinical Lymphoma, Myeloma & Leukemia|November 6, 2017
Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients With Diffuse Large B-cell Lymphoma (DLBCL) in Long-term RemissionMatthew C Cheung, Nicole Mittmann, Craig C Earle, et al.Plos One|October 12, 2017
Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort studyHla-Hla Thein, Kika Anyiwe, Nathaniel Jembere, et al.Journal of Thoracic Disease|October 18, 2021
Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in CanadaKirstin Perdrizet, Rinku Sutradhar, Qing Li, et al.Journal of the American College of Surgeons|February 21, 2009
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancerMonika K Krzyzanowska, Meredith M Regan, Mark Powell, et al.Pageof 37